glatiramer acetate
Generic: glatiramer
Labeler: mylan pharmaceuticals inc.Drug Facts
Product Profile
Brand Name
glatiramer acetate
Generic Name
glatiramer
Labeler
mylan pharmaceuticals inc.
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
glatiramer acetate 40 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
0378-6961
Product ID
0378-6961_f5070abd-2219-47fa-8ff2-c0b147ea3eb7
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA206936
Listing Expiration
2026-12-31
Marketing Start
2017-10-04
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
03786961
Hyphenated Format
0378-6961
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
glatiramer acetate (source: ndc)
Generic Name
glatiramer (source: ndc)
Application Number
ANDA206936 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 40 mg/mL
Packaging
- 12 BLISTER PACK in 1 CARTON (0378-6961-12) / 1 SYRINGE in 1 BLISTER PACK (0378-6961-32) / 1 mL in 1 SYRINGE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "f5070abd-2219-47fa-8ff2-c0b147ea3eb7", "openfda": {"unii": ["5M691HL4BO"], "rxcui": ["1487361"], "spl_set_id": ["456a34c7-8511-4000-99a7-ad8f8de6d35e"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "12 BLISTER PACK in 1 CARTON (0378-6961-12) / 1 SYRINGE in 1 BLISTER PACK (0378-6961-32) / 1 mL in 1 SYRINGE", "package_ndc": "0378-6961-12", "marketing_start_date": "20171004"}], "brand_name": "Glatiramer Acetate", "product_id": "0378-6961_f5070abd-2219-47fa-8ff2-c0b147ea3eb7", "dosage_form": "INJECTION, SOLUTION", "product_ndc": "0378-6961", "generic_name": "Glatiramer", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Glatiramer Acetate", "active_ingredients": [{"name": "GLATIRAMER ACETATE", "strength": "40 mg/mL"}], "application_number": "ANDA206936", "marketing_category": "ANDA", "marketing_start_date": "20171004", "listing_expiration_date": "20261231"}